logo
Oxford University Press to stop publishing China-sponsored science journal

Oxford University Press to stop publishing China-sponsored science journal

The Guardian4 days ago
Oxford University Press (OUP) will no longer publish a controversial academic journal sponsored by China's Ministry of Justice after years of concerns that several papers in the publication did not meet ethical standards about DNA collection.
A statement published on the website of Forensic Sciences Research (FSR) states that OUP will stop publishing the quarterly journal after this year.
FSR is a journal that comes from China's Academy of Forensic Science, an agency that sits under the Ministry of Justice. The academy describes FSR as 'the only English quarterly journal in the field of forensic science in China that focuses on forensic medicine'. It has been published by OUP since 2023.
Several papers published in FSR have attracted criticism because they study genetic data from Uyghurs and other heavily surveilled ethnic minorities in China. Critics say subjects in the studies may not have freely consented to their DNA samples being used in the research and that the studies could help to enhance the mass surveillance of those populations.
One study, published in 2020, analysed blood samples from 264 Uyghurs in Ürümqi, the capital of the Xinjiang region in north-west China. The paper states that the people giving the samples consented to the research and that their data was anonymised.
The lead author on the study is affiliated with China's state security apparatus via the Xinjiang Police College, which provided a research grant.
In 2024, OUP published an 'expression of concern' about the article, responding to questions about whether or not Uyghurs in Xinjiang could freely refuse to participate in a study conducted by representatives of China's state security. The paper has not been retracted.
Two other papers published in FSR based on DNA samples from Chinese populations have been retracted by OUP since 2023 because of ethical concerns. In both cases, several of the researchers came from Chinese police authorities.
Forensic science research is often carried out under the auspices of police authorities, but in China, where there the state security apparatus is not subject to checks and balances, there is concern this kind of research may not meet international ethical standards.
Uyghurs in Xinjiang are subject to intense surveillance by state authorities and between 2016 and 2018 about a million of them are estimated to have been detained in what China calls 'vocational training centres'. The UN said China's policies in Xinjiang could constitute crimes against humanity. There are also reports of Xinjiang authorities collecting DNA samples from millions of Uyghurs under the guise of health checks, but which Uyghurs and human rights groups have said are compulsory and designed to enhance surveillance.
Yves Moreau, a professor of engineering at the University of Leuven in Belgium who focuses on DNA analysis, first raised concerns about OUP's relationship with FSR and about several studies. He said he was grateful for OUP's decision but that the brief public statement on the matter 'fails to address the important issues at stake'.
A statement published on FSR's website, which is hosted by OUP, said: 'Forensic Sciences Research will no longer be published by Oxford University Press (OUP) after the 2025 volume. The last issue published by OUP will be Volume 10, Issue 4.'
OUP acquired the journal in 2023. Under the terms of the publishing agreement between OUP and the Academy of Forensic Sciences, a copy of which was seen by the Guardian, the deal gave OUP the right to solicit paid advertisers in the pages of the journal. The agreement also gives OUP the right to collect any revenues received by the Academy of Forensic Sciences related to the journal.
OUP declined to elaborate on why it was ending the relationship with FSR.
In recent years there has been increasing scrutiny about the ethical standards of genetic research papers from China. Last year, a genetics journal from a leading scientific publisher retracted 18 papers from China due to concerns about human rights.
The concerns centre on whether or not vulnerable populations in China can freely refuse to participate, especially when researchers come from organisations, such as the police, affiliated with state security. There are also concerns that this kind of forensic DNA sampling could produce research that enhances the mass surveillance of those populations.
Moreau said: 'Forensic genetics is an area where specific caution is needed because this is the research that powers police DNA identification and databases. While DNA identification is a valuable technique to help solve crimes, it can raise privacy and ethical issues.' He added that the mass surveillance of minorities in Xinjiang and Tibet made China a particularly challenging country to enforce international norms about ethical research and human rights.
FSR's launch in 2016 was accompanied by an editorial that stated it is sponsored by an affiliate of China's Ministry of Justice. Duarte Nuno Vieira, the co-editor-in-chief of FSR, has previously denied financial support from China's Ministry of Justice had any impact on the journal's editorial policies.
Nuno Vieira did not respond to a request for comment. But in an article published on Tuesday, the FSR editors wrote that the journal was at 'a moment of transformation, firmly rooted in its past successes, and yet reaching with confident hands towards an even more luminous future'. The publication of the journal will be taken over by KeAi, a China-based joint venture run by the Dutch scientific publisher Elsevier and a Chinese partner.
China's Ministry of Justice and the Academy of Forensic Sciences did not respond to a request for comment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New 'super-Viagra' is 10 times stronger than famous little blue pill and could have fewer side effects, scientists say
New 'super-Viagra' is 10 times stronger than famous little blue pill and could have fewer side effects, scientists say

Daily Mail​

timea day ago

  • Daily Mail​

New 'super-Viagra' is 10 times stronger than famous little blue pill and could have fewer side effects, scientists say

A new 'super-Viagra' could be ten times stronger than the famous little blue pill and comes with fewer side effects scientists have revealed. The experimental drug simenafil was tested on 706 men by a team at Peking University First Hospital in China. And the results were staggering. The tests showed that after 12 weeks, the course of pills improved erectile function by more than 12 per cent. Scientists found that the original Viagra, known as sildenafil, only caused an approximately 11.8 per cent improvement compared to super-Viagra's 12.3 per cent results, and it found other brands were even less effective. And the dose is considerably smaller, with improvements seen using just 5mg compared to the standard 50mg dose of Viagra, according to The Sun. Erectile dysfunction is very common and often affects men over 40 years old. Symptoms usually include an inability to get an erection or an inability to maintain one. Most men struggle to get or keep an erection at some point, this can usually be caused by stress, tiredness or drinking too much alcohol. However if it is a common occurrence it may be a result of high blood pressure or cholesterol, diabetes, depression or anxiety and hormones problems and is something that can be discussed with a GP. Drugs on offer include traditional Viagra which is part of a drug group called PDE5 inhibitors. They work by blocking an enzyme that restricts blood flow to the penis, by blocking it, the normal function can resume and the penis can be become erect. Side effects can include headaches, sickness, hot flushes, indigestion, a stuffy nose or feeling dizzy. Writing in the Journal of Sexual Medicine, study author Dr Hui Jiang said: 'Owing to these adverse events, novel and alternative therapies are needed for patients with erectile dysfunction. 'The results so far show oral simenafil was effective and well-tolerated in male patients. 'Therefore, we believe that it will provide an additional reliable treatment option. 'Overall, the evaluation indicated that simenafil was as effective as other PDE5 inhibitors even at very low doses. 'It showed that intercourse satisfaction, orgasmic function, sexual desire and overall satisfaction increased.' The development comes as GPs warn of a staggering rise in erectile problems in young men. According to doctors, watching pornography is driving a wave of erectile dysfunction. Dr Babak Ashrafi, a family medic with Superdrug Online Doctor, said there had been an 46 per cent increase in men under the age of 30 currently seeking help from its erectile dysfunction service compared to last year. But Dr Babak said a spike in younger men experiencing the problem could be linked to the 'exponential' consumption of explicit online material. 'Despite men between the ages of 45 and 54 being the most likely to suffer from erectile difficulties, younger male audiences are increasingly requesting treatment,' he said. Dr Babak explained that while occasional pornography viewing was harmless, frequent or marathon sessions could re-train men's brains and prevent them from becoming aroused normally. 'Repeated overexposure to graphic content can over time make it harder for individuals to become aroused by real-life sexual experiences,' he said. The family doctor added that porn could be giving men unrealistic perceptions about their manhood, or how long they should last in bed.

New SUPER-Viagra pill is stronger and could have fewer side effects, scientists find
New SUPER-Viagra pill is stronger and could have fewer side effects, scientists find

The Sun

time2 days ago

  • The Sun

New SUPER-Viagra pill is stronger and could have fewer side effects, scientists find

SCIENTISTS are developing a new super-Viagra that is stronger than the little blue pill at just a tenth of the dose. Experimental drug simenafil was tested on 706 men by a team at the Peking University First Hospital in China. 1 Results showed that 12 weeks of treatment improved men's erectile function by an average of 12.3 per cent. The scientists said original Viagra, known as sildenafil, caused an approximately 11.8 per cent improvement in studies and other brands are less effective. The real catch is that the dose is tiny in comparison, they added – just 5mg compared to a standard 50mg dose of Viagra. This could make it cheaper or reduce the risk of side effects. The drugs are called PDE5 inhibitors and work by blocking an enzyme that restricts blood flow to the penis, causing it to relax and function normally for sex. Unwanted side effects might include headaches, sickness, hot flushes, indigestion, a stuffy nose or feeling dizzy. 'Effective at low doses' Writing in the Journal of Sexual Medicine, study author Dr Hui Jiang said: 'Owing to these adverse events, novel and alternative therapies are needed for patients with erectile dysfunction. 'The results so far show oral simenafil was effective and well-tolerated in male patients. 'Therefore, we believe that it will provide an additional reliable treatment option. 'Overall, the evaluation indicated that simenafil was as effective as other PDE5 inhibitors even at very low doses. 'It showed that intercourse satisfaction, orgasmic function, sexual desire and overall satisfaction increased.' Erectile dysfunction is common and becomes more likely with age, illness and weight gain. What is Erectile Dysfunction? At least half of men are expected to suffer once they get into middle and old age. NHS doctors last year prescribed record amounts of bedroom-boosting drugs like Viagra, dishing out 4.7million prescriptions at a cost of £17.6million.

Oxford University Press scraps China-sponsored journal after longstanding protests
Oxford University Press scraps China-sponsored journal after longstanding protests

The Independent

time3 days ago

  • The Independent

Oxford University Press scraps China-sponsored journal after longstanding protests

Oxford University Press will cease publishing the Chinese government-sponsored journal, Forensic Sciences Research, after 2025. The decision follows years of controversy regarding the journal's alleged ethical breaches over DNA collection from Uyghur and other ethnic minority groups in China. Critics highlighted concerns that studies published in the journal used DNA samples from minorities without their consent. OUP had previously retracted at least two papers and issued an "expression of concern" for another due to these ethical issues. Forensic Sciences Research will be published by KeAi in China from next year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store